Beijing Tiantan Biological Products Co., Ltd. (600161.SS) SHH
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
Currency In CNY
Sector
Healthcare
Industry
Biotechnology
Employees
5298
First IPO Date
June 16, 1998
| Name | Title | Pay | Year Born |
| Hui Chuan Yang | GM & Director | 0 | 1969 |
| Hongqing Wang | CFO & Board Secretary | 0 | 1982 |
| Yanlin He | Deputy GM & Director | 0 | 1968 |
| Ding Yu | Deputy General Manager | 0 | 1976 |
| Yana Liu | Deputy GM & Director | 0 | 1976 |
Beijing Tiantan Biological Products Co., Ltd., established in 1998 and headquartered in Beijing, China, is actively involved in the full spectrum of blood product operations within China. This includes pioneering research and development, manufacturing, sales, and providing consultancy services. Its comprehensive product line features critical blood-derived medicines such as intravenous immunoglobulin, human albumin, and various specialized human immunoglobulins for conditions like hepatitis B (both standard and freeze-dried formulations) and tetanus, alongside other general human immunoglobulin preparations and intravenous blood system solutions. The company operates as a subsidiary of China National Biotec Group Company Limited.